MUC1 and cancer: Along these lines, anti-Tn-MUC1-N CAR-T cells developed by Dr. Carl June have entered a Phase 1 CART-TnMUC1-01 trial, which is now underway for therapy for patients with TnMUC1-positive advanced cancers (Tmunity Therapeutics).